Navigating the Impact of Chemotherapy Shortages on Cancer Care and Finances
Pharmaceutical, gynecologic oncology, and physician perspectives shed light on potentially mitigating the ongoing carboplatin and cisplatin shortages’ effects on cancer care in the United States.
Strategies for Stabilizing Chemo Prices During Ongoing Drug Shortage
Implementing tax benefits for manufacturers who produce chemotherapy drugs may be one solution to increase drug production in the United States, according to Lucio N. Gordan, MD.
Expert Discusses Navigating Higher Prices of Chemotherapy Drugs Amid Shortage
Lucio N. Gordan, MD, describes how his practice deals with increasing costs of limited chemotherapy agents to ensure that patients with cancer continue to receive treatment.
Oncology Practices Must ‘Stay United’ to Manage Chemo Shortages
Lucio N. Gordan, MD, also discusses how increasing domestic manufacturing of chemotherapy may help in alleviating the ongoing shortages of carboplatin and cisplatin in the United States.
The Long Road-and the High Road-to Successful Implementation of OncoEMR
What distinguishes those practices that are successful in their use of the EMR is their commitment to the product and their recognition that it is the central element in the treatment of their patients.